AAAAAA
Results: 1-25/33
Authors:
ROBAK T
GLADALSKA A
STEPIEN H
Citation: T. Robak et al., THE TUMOR-NECROSIS-FACTOR FAMILY OF RECEPTORS LIGANDS IN THE SERUM OFPATIENTS WITH RHEUMATOID-ARTHRITIS/, European cytokine network, 9(2), 1998, pp. 145-154
Authors:
KOMOROWSKI J
JANKIEWICZ J
ROBAK T
BLASINSKAMORAWIEC M
STEPIEN H
Citation: J. Komorowski et al., CYTOKINES SERUM LEVELS AS THE MARKERS OF THYROID ACTIVATION IN GRAVES-DISEASE, Immunology letters, 60(2-3), 1998, pp. 143-148
Authors:
SMOLEWSKI P
NIEWIADOMSKA H
BLONSKI JZ
ROBAK T
KRYKOWSKI E
Citation: P. Smolewski et al., EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND P53, BCL-2 OR C-ERB B-2 PROTEINS ON REED-STERNBERG CELLS - PROGNOSTIC-SIGNIFICANCE IN HODGKINS-DISEASE, Neoplasma, 45(3), 1998, pp. 140-147
Authors:
SMOLEWSKI P
NIEWIADOMSKA H
BLONSKI JZ
ROBAK T
Citation: P. Smolewski et al., PRETREATMENT IMMUNOHISTOCHEMICAL PATTERN OF REED-STERNBERG AND HODGKINS CELLS IN RESPONDING AND NON-RESPONDING PATIENTS WITH HODGKINS-DISEASE - CELLULAR EXPRESSION OF ONCOPROTEINS INVOLVED IN APOPTOSIS REGULATION, British Journal of Haematology, 102(1), 1998, pp. 117-117
Authors:
BLONSKI JZ
CHRUCCIEL J
NIEWIADOMSKA H
SZYMCZYK P
ROBAK T
KILIANSKA ZM
Citation: Jz. Blonski et al., NUCLEAR-PROTEIN P44 - POTENTIAL MARKER OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 127-127
Authors:
BLASINSKAMORAWIEC M
BLONSKI JZ
ROBAK T
Citation: M. Blasinskamorawiec et al., CORRELATION OF SEVERAL CYTOKINES AND THEIR SOLUBLE RECEPTORS WITH CLINICAL, HEMATOLOGICAL AND IMMUNOLOGICAL PARAMETERS IN UNTREATED PATIENTS WITH B-CELL LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 128-128
Authors:
KORYCKA A
ROBAK T
Citation: A. Korycka et T. Robak, THE INFLUENCE OF AMIFOSTINE (ETHYOL) USED ALONE AND IN COMBINATION WITH 2-CHLORODEOXYADENOSINE (2-CDA) ON NORMAL AND LEUKEMIC GRANULOCYTE-MACROPHAGE PROGENITOR CELLS (CFU-GM) IN CULTURE IN-VITRO, British Journal of Haematology, 102(1), 1998, pp. 183-183
Authors:
HELLMANN A
LEWANDOWSKI K
ZAUCHA JM
BIENIASZEWSKA M
ROBAK T
Citation: A. Hellmann et al., TREATMENT OF WALDENSTROMS-MACROGLOBULINEMIA WITH 2-CHLORODEOXYADENOSINE, British Journal of Haematology, 102(1), 1998, pp. 244-244
Authors:
ROBAK T
GORATYBOR J
URBANSKARYS H
KRYKOWSKI E
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (CLADRIBINE), MITOXANTRONE AND DEXAMETHASONE (CMD) PROGRAM IN THE TREATMENT OF REFRACTORY AND RECURRENT LOW-GRADE NON-HODGKINS-LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 244-244
Authors:
ROBAK E
SYSAJEDRZEJOWSKA A
STEPIEN H
ROBAK T
Citation: E. Robak et al., CIRCULATING INTERLEUKIN-6 TYPE CYTOKINES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, European cytokine network, 8(3), 1997, pp. 281-286
Authors:
ROBAK T
GORATYBOR J
KRYKOWSKI E
WALEWSKI JA
BORAWSKA A
PLUZANSKA A
POTEMSKI P
HELLMANN A
ZAUCHA JM
KONOPKA L
CEGLAREK B
DURZYNSKI T
SIKORSKA A
MICHALAK K
URASINSKI J
OPALINSKA J
DMOSZYNSKA A
ADAMCZYKCIOCH MB
KURATOWSKA Z
DWILEWICZTROJACZEK J
BOGURADZKI P
DEREN M
MAJ S
GRIEB P
Citation: T. Robak et al., ACTIVITY OF 2-CHLORODEOXYADENOSINE (CLADRIBINE) IN 2-HOUR INTRAVENOUS-INFUSION IN 94 PREVIOUSLY TREATED PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 26(1-2), 1997, pp. 99-105
Authors:
BLASINSKAMORAWIEC M
ROBAK T
KRYKOWSKI E
HELLMANN A
URBANSKARYS H
Citation: M. Blasinskamorawiec et al., HAIRY-CELL LEUKEMIA-VARIANT TREATED WITH 2-CHLORODEOXYADENOSINE - A REPORT OF 3 CASES, Leukemia & lymphoma, 25(3-4), 1997, pp. 381-385
Authors:
ROBAK T
BLASINSKAMORAWIEC M
BLONSKI JZ
KRYKOWSKI E
KOMARNICKI M
TREPINSKA E
KAZMIERCZUK M
HANSZ J
DMOSZYNSKA A
ROLINSKI J
KONOPKA L
SKOTNICKI AB
NOWAK WS
KOTLAREKHAUS S
ZDZIARSKA B
URASINSKI I
Citation: T. Robak et al., THE EFFECT OF 2-H INFUSION OF 2-CHLORODEOXYADENOSINE (CLADRIBINE) WITH PREDNISONE IN PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, European journal of cancer, 33(14), 1997, pp. 2347-2351
Authors:
WARZOCHA K
FABIANOWSKAMAJEWSKA K
BLONSKI J
KRYKOWSKI E
ROBAK T
Citation: K. Warzocha et al., 2-CHLORODEOXYADENOSINE INHIBITS ACTIVITY OF ADENOSINE-DEAMINASE AND S-ADENOSYLHOMOCYSTEINE HYDROLASE IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA, European journal of cancer, 33(1), 1997, pp. 170-173
Authors:
ROBAK T
BLASINSKAMORAWIEC M
KRYKOWSKI E
HELLMANN A
LEWANDOWSKI K
DMOSZYNSKA A
ADAMCZYKCIOCH M
KAZIMIERCZAK M
TREPINSKA E
DWILEWICZTROJACZEK M
KURATOWSKA Z
SKOTNICKI AB
NOWAK WS
ZDZIARSKA B
URASINSKI I
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (CLADRIBINE)-RELATED EOSINOPHILIA IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES, European journal of haematology, 59(4), 1997, pp. 216-220
Authors:
ROBAK T
BLASINSKAMORAWIEC M
KRYKOWSKI E
HELLMANN A
KONOPKA L
Citation: T. Robak et al., AUTOIMMUNE HEMOLYTIC-ANEMIA IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA TREATED WITH 2-CHLORODEOXYADENOSINE (CLADRIBINE), European journal of haematology, 58(2), 1997, pp. 109-113
Authors:
GORATYBOR J
ROBAK T
Citation: J. Goratybor et T. Robak, DOES INTERLEUKIN-2 ENHANCE THE ANTITUMOR-ACTIVITY OF 2-CHLORODEOXYADENOSINE, The Cancer journal, 10(3), 1997, pp. 171-174
Authors:
ROBAK T
SZWAROCKA A
PRZYBYLSKA M
WRZESIENKUS A
KRYKOWSKI E
JOZWIAK Z
Citation: T. Robak et al., ALTERATIONS OF THE ERYTHROCYTE-MEMBRANE ORGANIZATION AFTER ADMINISTRATION OF DAUNORUBICIN TO PATIENTS WITH ACUTE LEUKEMIAS, Experimental hematology, 25(8), 1997, pp. 450-450
Authors:
KORYCKA A
ROBAK T
Citation: A. Korycka et T. Robak, THE INFLUENCE OF RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR-ALPHA AND ITS MUTEINS USED ALONE OR IN COMBINATION WITH 2-CHLORODEOXYADENOSINE ON NORMAL AND LEUKEMIC HEMATOPOIESIS IN-VITRO, Leukemia research, 21(9), 1997, pp. 857-865
Authors:
ROBAK T
SYSAJEDRZEJOWSKA A
ROBAK E
DABKOWSKI J
BLASINSKAMORAWIEC M
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (CLADRIBINE) INDUCED ALLERGIC CUTANEOUS REACTIONS WITH EOSINOPHILIA IN A PATIENT WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of medicine, 28(3-4), 1997, pp. 199-209
Authors:
ROBAK T
BLASINSKAMORAWIEC M
BLONSKI JZ
KRYKOWSKI E
DMOSZYNSKA A
SKOTNICKI AB
KONOPKA L
HELLMANN A
KURATOWSKA Z
URASINSKI I
KOTLAREKHAUS S
MAJ S
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (2-CDA) AND PREDNISONE(P) VERSUS CHLORAMBUCIL (CHL) AND PREDNISONE AS A FIRST LINE THERAPY IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 90(10), 1997, pp. 2361-2361
Authors:
ROBAK T
BLASINKAMORAWIEC M
KRYKOWSKI E
KASZNICKI M
PLUZANSKA A
POTEMSKI P
HELLMANN A
ZAUCHA JM
LEWANDOWSKI K
DMOSZYNSKA A
HANSZ J
KOMARNICKI M
KONOPKA I
DURZYNSKI T
CEGLAREK B
SIKORSKA A
KOTLAREKHAUS S
MAZUR G
URASINSKI I
ZDZIARSKA B
MAJ S
KOPEC I
SKOTNICKI AB
DWILEWICZTROJACZEK J
KURATOWSKA Z
GRIEB P
Citation: T. Robak et al., INTERMITTENT 2-HOUR INTRAVENOUS INFUSIONS OF 2-CHLORODEOXYADENOSINE IN THE TREATMENT OF 110 PATIENTS WITH REFRACTORY OR PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 22(5-6), 1996, pp. 509-514
Authors:
ROBAK T
BLASINSKAMORAWIEC M
KRYKOWSKI E
HANSZ J
KOMARNICKI M
KAZIMIERCZAK M
KONOPKA L
MAJ S
HELLMANN A
ZAUCHA JM
URASINSKI L
ZDZIARSKA B
KOTLAREKHAUS S
USNARSKAZUBKIEWICZ L
KURATOWSKA Z
DWILEWICZTROJACZEK J
HOLOWIECKI J
KRAWCZYKKULIS M
GRIEB P
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (2-CDA) IN 2-HOUR VERSUS 24-HOUR INTRAVENOUS-INFUSION IN THE TREATMENT OF PATIENTS WITH HAIRY-CELL LEUKEMIA, Leukemia & lymphoma, 22(1-2), 1996, pp. 107-111
Authors:
WARZOCHA K
KRYKOWSKI E
GORATYBOR J
FRONCZAK A
ROBAK T
Citation: K. Warzocha et al., FULMINANT 2-CHLORODEOXYADENOSINE-RELATED PERIPHERAL NEUROPATHY IN A PATIENT WITH PARANEOPLASTIC NEUROLOGICAL SYNDROME-ASSOCIATED WITH LYMPHOMA, Leukemia & lymphoma, 21(3-4), 1996, pp. 343-346
Authors:
ROBAK T
KORYCKA A
Citation: T. Robak et A. Korycka, THE COMPARISON OF 2-CHLORODEOXYADENOSINE (2-CD-A) IN COMBINATION WITHINTERFERON-ALPHA (IFN-ALPHA) OR INTERFERON-GAMMA (IFN-GAMMA) ON GRANULOCYTE-MACROPHAGE PROGENITOR CELLS (CFU-GM) AND CLONOGENIC BLASTS IN (CFU-L) IN-VITRO CULTURES, Leukemia & lymphoma, 21(1-2), 1996, pp. 161-168